Forced and long-term degradation assays of tenoxicam, piroxicam and meloxicam in river water. Degradation products and adsorption to sediment.

[1]  A. Nicolau,et al.  High sensitive multiresidue analysis of pharmaceuticals and antifungals in surface water using U-HPLC-Q-Exactive Orbitrap HRMS. Application to the Danube river basin on the Romanian territory. , 2015, The Science of the total environment.

[2]  Longshan Zhao,et al.  LC-QTOF-MS method for the analysis of residual pharmaceuticals in wastewater: application to a comparative multiresidue trace analysis between spring and winter water , 2014 .

[3]  P. Turner,et al.  Aqueous stability and oral pharmacokinetics of meloxicam and carprofen in male C57BL/6 mice. , 2013, Journal of the American Association for Laboratory Animal Science : JAALAS.

[4]  A. Kamel,et al.  The pharmacokinetics and metabolism of meloxicam in camels after intravenous administration. , 2012, Journal of veterinary pharmacology and therapeutics.

[5]  Ravi P. Shah,et al.  Successful characterization of degradation products of drugs using LC-MS tools: Application to piroxicam and meloxicam , 2011 .

[6]  T. Ebner,et al.  Excretion mass balance evaluation, metabolite profile analysis and metabolite identification in plasma and excreta after oral administration of [14C]-meloxicam to the male cat: preliminary study. , 2010, Journal of veterinary pharmacology and therapeutics.

[7]  P. Vavia,et al.  A Stability Indicating HPLC Method for the Determination of Meloxicam in Bulk and Commercial Formulations , 2009 .

[8]  M. Hedeland,et al.  A mass spectrometric study on meloxicam metabolism in horses and the fungus Cunninghamella elegans, and the relevance of this microbial system as a model of drug metabolism in the horse. , 2009, Journal of mass spectrometry : JMS.

[9]  L. Suntornsuk,et al.  Spectrophotometric method for the simulta­ neous determination of piroxicam and 2-aminopyridine , 2005 .

[10]  C. Suann,et al.  The detection of piroxicam, tenoxicam and their metabolites in equine urine by electrospray ionisation ion trap mass spectrometry. , 2004, Rapid Communications in Mass Spectrometry.

[11]  A. Site.  Factors Affecting Sorption of Organic Compounds in Natural Sorbent/Water Systems and Sorption Coefficients for Selected Pollutants. A Review , 2001 .

[12]  R. Leavitt,et al.  The elimination profiles of tenoxicam and hydroxytenoxicam in equine urine and serum after a 200-mg oral dose. , 1999, Journal of analytical toxicology.

[13]  P. Milligan.  Determination of piroxicam and its major metabolites in the plasma, urine and bile of humans by high-performance liquid chromatography. , 1992, Journal of Chromatography A.

[14]  W. Meister,et al.  Determination of tenoxicam, and the isolation, identification and determination of Ro 17-6661, its major metabolite, in human urine. , 1984, Journal of chromatography.

[15]  S. Girisham,et al.  Biotransformation of meloxicam by Aspergillus fumigatus and Fusarium moniliforme isolated from soil , 2009 .

[16]  M. I. Albero,et al.  Simultaneous determination of piroxicam and its major metabolite 5'-hydroxypiroxicam in human plasma by derivative spectrophotometry. , 1998, The Analyst.